Found 40 matching trials
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI) PHASE4 Transcatheter aortic valve implantation (TAVI) is a rapidly growing treatme...
Show More Learn More & Join Trial
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy PHASE4 The study goal is to determine the clinical benefit of percutaneous cathete...
Show More Location
Charité Universitätsmedizin Berlin, Klinik für Kardiologie, Angiologie und Intensivmedizin, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin (CBF)
Learn More & Join Trial
Registration of Idarucizumab for Patients with IntraCranial Hemorrhage N/A This multicenter, prospective, observational, non-interventional study inve...
Show More Location
Klinikum Schön Klinik Bad Aibling SE & Co. KG
Learn More & Join Trial
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients N/A The same initial and long-term anticoagulation is suggested for unsuspected...
Show More Location
D.C. Veterans Affairs Medical Center
Learn More & Join Trial
APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF PHASE4 It is hypothesised that a dual therapy strategy by oral anticoagulation wit...
Show More Location
Munich University Hospital
Learn More & Join Trial
Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) PHASE3 The Study is an open-labeled, randomized controlled trial, phase IIIb. Its ...
Show More Location
Universitätsklinikum Münster
Learn More & Join Trial
Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy PHASE4 Study objective is to demonstrate that anticoagulation with the direct fact...
Show More Location
Montefiore Medical Center
Learn More & Join Trial
Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon PHASE4 Oral anticoagulation is often initiated in hospitalized patients. Although ...
Show More Location
Cantonal Hospital St. Gallen
Learn More & Join Trial
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion PHASE3 A study for patients with abnormal heart rhythm (atrial fibrillation) who n...
Show More Location
Multiple Locations
Learn More & Join Trial
EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon PHASE4 Rationale:
The narrow therapeutic range and wide inter-patient variability...
Show More Location
Elisabethinen Hospital Linz
Learn More & Join Trial